ghardaianews

Corona virus surprises us with its branched and mutated strains, with which all safety measures should be taken for all age groups, and for this reason, vaccinating children with Corona vaccines has become a top priority now in most European countries and America as well.

This necessity comes after the delta mutated new strain of the Corona virus has spread in many countries of the world, and Delta is considered the best and most severe version of the virus so far, as it is highly contagious.

With the school season approaching, all parents are concerned about their children, for fear of infection, and this is why it is necessary to vaccinate children and immunize them against the virus and the new variant of it.

At the present time, the category of children from the age of 12 years and older is considered the lucky one to be able to get the vaccine, according to the studies that have been conducted during the last period, but fortunately for the age groups younger than 12 years, the vaccine will be available to them soon.

As for the studies and clinical trials that are currently being conducted on children to determine the Corona vaccines, they are as follows:

• At the fore are the vaccines of the “Pfizer” and “Moderna” companies, because they have launched comprehensive trials of the Corona virus vaccine on children up to six months of age since last March, and the results of these experiments will be ready during the next short period, especially in the month of next September.
• As for Johnson & Johnson, it is currently collecting and arranging the results of its clinical trials about its vaccine for children between the ages of 12 and 17 years. They also plan to start new studies and trials of their vaccine for children between the ages of two and 11 years, during the coming period.
• As for Novavax, it is on its way to end its trials for age groups from 18 years of age to older, and is also focusing on collecting and analyzing data about its vaccine to ensure its efficacy and safety for age groups from 12 to 17 years.

Another important part that researchers and companies focus on is the safe dose of vaccines and what is best for each age group. For adults, the doses they receive are identical.

As for children, safe doses are studied for them, and clinical trials focus on this matter. Children in these trials are divided into separate age groups and stages, and for each age stage, the safe dose is tested for them according to the child’s growth and development.

The evidence for this is that the experiments conducted by Pfizer are divided into different stages according to the ages of the children. Children from 5 to 11 years old are in a separate stage, children from 2 to 5 years old are in a separate stage of their own, and children from six months to two years of age also have a stage. Their own.

They all take the same vaccine, but with different doses. The younger age group has a lower dose compared to the older age group of children.

And all the companies that requested medical permission to test their vaccine on children, especially children under 12 years old, the results of their studies and experiments must be delivered to the Food and Drug Administration (FDA) within a period of 4 to 6 months, and many of them began their experiments in the month of last March, meaning that little remained on the appearance of The results are as they said by next month.

The results for each company should indicate whether its vaccine is safe or not for children, as well as whether it is effective. The Food and Drug Administration also made it clear that companies that are about to provide all the results, especially “Pfizer” and “Moderna” companies, can request permission to use the vaccine in an emergency situation.

And the indications that have appeared so far show that the nearest vaccine will be available for children in the fall of this year, especially for children from 5 to 11 years old.

Pfizer is now seeking to share the results of its studies on its vaccine as soon as possible, by September or October, at the latest, to obtain official permission to vaccinate children from 5 to 11 years of age, especially since its vaccine is the only approved vaccine for children from 12 to 17 years old. common in America.

As for Moderna, it has also set itself the same schedule as Pfizer Inc. to present the results of the safety and efficacy of its vaccine for children, especially from 12 to 17 years of age, for approval and vaccination, as its vaccine is only approved for ages over 18 years old now.

As for infants and younger children, it is expected that the vaccine will be authorized for them during the coming winter, because companies are conducting their clinical trials from the older and younger age groups to study the safety of the vaccine for each category.

As results emerge for older age groups in children, clinical trials for younger children will be faster and more straightforward for researchers. Now, the vaccine is available for children from 12 years of age to older than that.. These groups are now vaccinated to pay attention to the younger age groups in the coming period, specifically next month.

The UAE and its plan to vaccinate children with Corona vaccines:

The UAE is one of the most active Arab countries in terms of vaccination with Corona vaccines for all age groups of its residents. Available there.

The UAE, as the first Arab country, responded to the recommendations to vaccinate children with the emerging corona vaccines to confront the most dangerous delta strain and ensure the safety of all its residents.

Abu Dhabi media books also confirmed the start of the trial of vaccinating children from 3 to 17 years old with the Chinese vaccine, Sinopharma, and some members of the ruling family there participated in this experiment to encourage children and their families to participate.

And now they are monitoring the immune response of all participating children, who now number 900, as part of a plan to vaccinate all UAE children to ensure their safety and health.